A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...

Scientists have sequenced the complete genome of a roundworm used extensively in biological research, opening a new pathway ...

Arvinas PROTAC protein degraders have some potential, with vepdegestrant as its late-stage, most promising asset, partnered ...

Median Overall Survival (OS) of 13.9 months in triple negative breast cancer (TNBC) exceeds Trodelvy (11.8 months) and doubles control (6.9 months) OS of 17.3 months in HR+ metastatic breast cancer ...

The phase 3 FORTITUDE-101 trial, conducted with the support of Zai Lab, has been evaluating bemarituzumab plus mFOLFOX6 ...

Brunch presenter Morgan McGlynn Carr has revealed she has been diagnosed with breast cancer and she shared the details in an ...

Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, ...

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is characterized by a high rate of metastasis ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Merus presented data from its Phase II study of petosemtamab, which is a bispecific monoclonal antibody targeting epidermal ...

The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, ...

BU researchers have now discovered that exosomes—messenger nanovesicles  that carry proteins, RNA, and other molecules to other cells—released into the blood by different organs and tissues in obese, ...